0001104659-24-074044.txt : 20240624 0001104659-24-074044.hdr.sgml : 20240624 20240621204645 ACCESSION NUMBER: 0001104659-24-074044 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240621 EFFECTIVENESS DATE: 20240624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-516643 FILM NUMBER: 241061801 BUSINESS ADDRESS: STREET 1: 377 PLANTATION STREET CITY: WORCESTER STATE: MA ZIP: 01605 BUSINESS PHONE: 7816524500 MAIL ADDRESS: STREET 1: 377 PLANTATION STREET CITY: WORCESTER STATE: MA ZIP: 01605 D 1 primary_doc.xml X0708 D LIVE 0001680048 MUSTANG BIO, INC. 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 7816524500 DELAWARE None None Corporation true Michael S. Weiss 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Director Lindsay A. Rosenwald, M.D. 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Director Neil Herskowitz 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Director Manuel B. Litchman, M.D. 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Executive Officer Director President and Chief Executive Officer Adam J. Chill 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Director Michael J. Zelefsky, M.D. 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Director James B Murphy 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 Executive Officer Interim Chief Financial Officer Biotechnology Decline to Disclose 06b false 2024-06-19 false true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue, 3rd Floor New York NY NEW YORK 10022 NY NEW YORK false 2513139 2513139 0 The offering amount reflects the aggregate purchase price received and exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investor and placement agent in the private placement under Rule 506(b). false 1 175931 0 In connection with the registered direct offering concurrent with the private placement, the placement agent received $175,931 and warrants to purchase up to 367,800 shares of common stock exercisable at $0.5125 per share. 0 false MUSTANG BIO, INC. /s/ Manuel B. Litchman, M.D. Manuel B. Litchman, M.D. President and Chief Executive Officer 2024-06-21